Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

May 13, 2014

284_dirs_2014-05-13_e5b93dd5-8686-4bd7-a227-a1bff7a3203e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-09

Reporting Person: Davis Robert M (Exec V-P & Chief Fince Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-09 Restricted Stock Unit $ A 85881.0000 Acquired 2017-05-09 Common Stock (85881.0000) Direct
2014-05-09 Stock Option (right to buy) $58.2200 A 192572.0000 Acquired 2024-05-08 Common Stock (192572.0000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: The option vests in three equal annual installments beginning May 9, 2015.